Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp209 | Thyroid 2 | ECE2017

The increased immunohistochemical expression of IL-23 in Hashimoto’s thyroiditis but not in Graves’ disease patients

Zake Tatjana , Skuja Sandra , Kalere Ieva , Konrade Ilze , Groma Valerija

Introduction: Recently, Th17 cells and their cytokines were identified to play an important role in the pathogenesis of thyroid autoimmunity. IL-23, produced by antigen presenting cells, is required for survival and differentiation of Th17 cells, and is known to guide T cells toward the Th17 phenotype. Its serum levels are increased in several autoimmune diseases, including Hashimoto’s thyroiditis (HT), however, the expression level of IL-23 within thyroid tissue assessed...

ea0041gp218 | Thyroid - Translational & Clinical (1) | ECE2016

Relationship between immunoexpression of IL17A, CD68 positivity and lymphocyte infiltration degree in Hashimoto’s thyroiditis patients

Konrade Ilze , Zake Tatjana , Skuja Sandra , Kalere Ieva , Groma Valerie

Introduction: Th17 cells and their hallmark cytokine IL-17A were reported to be involved in the development of autoimmune orchitis and encephalomyelitis by impairing the integrity of the blood–testis and blood–brain barrier integrity and by inducing local inflammation. However, the role of IL17A in autoimmune thyroid disease is still debatable.The aim of our study was to estimate immunoexpression of IL-17A in the thyroid tissue of patients with...

ea0037ep1195 | Clinical Cases–Pituitary/Adrenal | ECE2015

Differential diagnosis of low renin hypertension – pseudohypoaldosteronism type 2

Kalere Ieva , Tonne Ieva , Lejnieks Aivars , Konrade Ilze

Introduction: Pseudohypoaldosteronism type 2 (PHA2), also known as Gordon syndrome is a rare inherited form of low-renin hypertension associated with hyperkalaemia and hyperchloremic metabolic acidosis in patients with a normal glomerular filtration rate (GFR). PHA2 is the result of mutations in a family of serine-threonine kinases called with-no-lysine kinases (WNK) 1 and WNK4. These enzymes regulate electron channels in the aldosterone sensitive distal nephron, resulting in ...

ea0070aep909 | Thyroid | ECE2020

Plasma levels of Th17 associated cytokines in patients with autoimmune thyroid disease

Zake Tatjana , Kalere Ieva , Upmale Sabine , Gersone Gita , Konrade Ilze

Introduction and aim: Cytokines play a crucial role in modulating immune response in both Hashimoto’s thyroiditis (HT) and Graves’ disease (GD). They may contribute to drive the autoimmune response skewing toward the Th17 phenotype and away from Th1 or Th2 phenotypes. Recent studies revealed an essential role of Th17 cells and their cytokines in the development of autoimmune thyroid diseases (AITD). However, participation of Th17 cells in the pathogenesis of GD is ...

ea0049oc6.3 | Diabetes therapy and complications | ECE2017

Alterations in DNA methylation from peripheral blood cells in humans threated with metformin

Klovins Janis , Elbere Ilze , Peculis Raitis , Kalnina Ineta , Zaharenko Linda , Konrade Ilze , Pirags Valdis

Metformin is a biguanide class agent widely used as a first-line treatment for type 2 diabetes, however the detailed mode of action and exact pharmacodynamics has not been clarified. Moreover there is no studies in humans displaying the effect of metformin on DNA methylation. We therefore performed a clinical study involving twelve healthy nondiabetic individuals who were subjected to the 1 week of metformin (2×850 mg/day) treatment. Peripheral blood for DNA isolation was...

ea0037ep522 | Diabetes (complications & therapy) | ECE2015

Association of SNPs in the intergenic region of OCT2 and OCT3 with short-term efficiency of metformin monotherapy in the type 2 diabetes patients

Klovins Janis , Zaharenko Linda , Geldnere Kristine , Konrade Ilze , Grinberga Solveiga , Pugovics Osvalds , Kalnina Ineta , Pirags Valdis

Clinical response to metformin is highly variable in type 2 diabetes (T2D) patients highlighting the need for identification of genetic components affecting the efficiency of metformin therapy. Aim of this study was to evaluate the role of systematically selected tagSNPs from genomic regions coding for six organic cation transporters implicated in transport of metformin with respect to the short-term efficiency. The study involved 102 drug naïve newly diagnosed T2D patien...

ea0037ep967 | Thyroid (non-cancer) | ECE2015

Immunohistochemical expression of Claudin-1 in Hashimoto's thyroiditis and Graves' disease patients

Zake Tatjana , Skuja Sandra , Pekarska Katrina , Groma Valerija , Konrade Ilze , Kleina Regina

Introduction: Autoimmune thyroid diseases, including Graves’ disease (GD) and Hashimoto’s thyroiditis (HT), are complex diseases combining genetic susceptibility and environmental encounters leading to the breakdown of immune tolerance. The relationship between thyroid cancer (TC) and HT has been proven (Guarino et al. 2010), and the antibody specific association has been demonstrated (Azizi et al. 2014). Overexpression of claudin-1 appears to be an...

ea0049ep931 | Pituitary - Basic | ECE2017

Whole exome sequencing of two non-secreting pituitary adenoma tumors from the same patient

Rovite Vita , Peculis Raitis , Balcere Inga , Stukens Janis , Konrade Ilze , Valtere Andra , Nazarovs Jurijs , Caune Olivija , Pirags Valdis , Klovins Janis

Pituitary adenomas (PA) are benign tumors that develop in pituitary gland. Hormone secreting PA can cause overproduction of pituitary hormones leading to different systemic endocrine disorders (acromegaly, Cushing’s disease and others). Non-secreting PA can promote headaches (stretching of the dural sheath) and visual field defects (chiasma compression). We managed to obtain resected tumor samples from the patient having non-secreting PA, first tumor was resected in 2010,...

ea0073pep3.7 | Presented ePosters 3: Pituitary and Neuroendocrinology | ECE2021

Transcriptome alteration landscape of pituitary neuroendocrine tumour tissue

Saksis Rihards , Megnis Kaspars , Peculis Raitis , Niedra Helvijs , Balcere Inga , Konrade Ilze , Steina Liva , Pirags Valdis , Rovite Vita

Pituitary neuroendocrine tumors (PitNETs) are non-metastatic neoplasms of the pituitary that may overproduce hormones leading to systemic disorders or tumor mass effects causing headache, vertigo, or visual impairment. The overall estimated clinical prevalence of PitNETs is 1 in 400 to 1 in 1000 people. Although the pathogenesis of PitNETs has been extensively studied the molecular factors underlying tumorigenesis, remission, and therapy response of PitNETs are still unclear. ...

ea0063p52 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Exome analysis of pituitary adenoma tissue derived cell cultures

Rovite Vita , Peculis Raitis , Mandrika Ilona , Petrovska Ramona , Megnis Kaspars , Balcere Inga , Konrade Ilze , Stukens Janis , Breiksa Austra , Nazarovs Jurijs , Pirags Valdis , Klovins Janis

Introduction: Pituitary adenomas (PA) are tumours of the anterior pituitary. Despite the benign nature these neoplasms cause increased mortality and morbidity. Clinically relevant PAs affect around 0.1% of population during their lifetime. Currently, there is no human PA cell culture models. Tissue cultures derived from PA surgery materials depending on harvesting conditions can form free floating aggregates called pituispheres (PS) or adherent mesenchymal stromal cells (MSC)....